Chiesi USA Updates Trimbow Prescribing Information for COPD Treatment (GeneOnline) - Oct 5, 2026 - "The medication serves as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema...The updated documentation outlines the specific pharmacological composition of the inhaler, which combines an inhaled corticosteroid, a long-acting beta2-adrenergic agonist, and a long-acting muscarinic antagonist. The information provided by the manufacturer details the clinical indications, dosage requirements, and safety protocols for the administration of the aerosol. These updates are now available through the National Library of Medicine’s DailyMed database, which serves as the official repository for current drug labeling and prescribing guidelines."
Commercial • Chronic Obstructive Pulmonary Disease • Immunology • Respiratory Diseases
|